Immune Activation in Measles

Diane E. Griffin, Brian J. Ward, Enrique Jauregui, Richard T. Johnson, Abraham Vaisberg

Research output: Contribution to journalArticlepeer-review

Abstract

Measles is associated with alterations in immune regulation that sometimes lead to secondary infections or autoimmune encephalomyelitis. Simultaneously, an effective measles virus–specific immune response develops. To relate immune activation to measles and its complications, we studied the spontaneous proliferation of blood mononuclear cells and circulating levels of soluble interleukin-2 receptor and CD8 T-cell antigens in 126 patients with complicated or uncomplicated measles at various stages of the disease. Spontaneous proliferation of mononuclear cells, which was present through the first week of the rash, was greater in cells from patients with measles (8787ケ1403 cpm) than in those from healthy children (1529ケ237 cpm, P<0.0001). Levels of soluble interleukin-2 receptor (3385ケ195 units per milliliter) and CD8 (4145ケ437 units per milliliter) were higher in patients with measles than in those with other infectious diseases (2377ケ440, P = 0.003; 2399ケ771, P = 0.0374) or in healthy children (865ケ138, P<0.0001; 1026ケ169, P<0.0001). Levels of soluble interleukin-2 receptor were elevated before the onset of the rash and remained elevated for several weeks. In contrast, levels of soluble CD8 increased only when the rash appeared, and subsided quickly. Spontaneous proliferation of mononuclear cells and levels of soluble CD8 were similar in patients with uncomplicated disease, pneumonia, or encephalomyelitis, but soluble interleukin-2 receptor levels were lower in patients with encephalomyelitis (2312ケ314 vs. 3455ケ247 units per milliliter in uncomplicated measles; P = 0.01). In patients with encephalomyelitis, cerebrospinal fluid levels of soluble CD8 (686ケ350 units per milliliter), but not interleukin-2 receptor (9ケ8.3 units per milliliter), were increased. We conclude that the proliferative phase of the immune response, as measured by the release of soluble interleukin-2 receptor, begins before the rash appears, continues for several weeks in those without complications, but does not occur within the nervous system. In contrast, the effector phase of the immune response, as measured by the release of soluble CD8, coincides with the appearance and disappearance of the rash and occurs within the nervous system during encephalomyelitis. (N Engl J Med 1989;320:1667–72.) MEASLES remains a major cause of morbidity and mortality in much of the world.1 Most of the serious complications of measles are due to secondary bacterial and viral infections causing pneumonia and diarrhea2 , 3 or to postmeasles encephalomyelitis, an autoimmune demyelinating disease.4 , 5 Both types of complications, infectious and autoimmune, are thought to be related to the immunologic abnormalities that accompany acute measles. These abnormalities include the suppression of delayed hypersensitivity6 , 7 and the reduction of mitogen-induced lymphoproliferation8 , 9 and lymphokine production10 in vitro in the presence of normal ratios of T-cell subsets.11 , 12 Peripheral-blood leukocytes are also activated in the acute phase of measles,.

Original languageEnglish (US)
Pages (from-to)1667-1672
Number of pages6
JournalNew England Journal of Medicine
Volume320
Issue number25
DOIs
StatePublished - Jun 22 1989

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Immune Activation in Measles'. Together they form a unique fingerprint.

Cite this